SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 52.16 |
| Enterprise Value ($M) | 94.64 |
| Book Value ($M) | 17.28 |
| Book Value / Share | 0.77 |
| Price / Book | 3.02 |
| NCAV ($M) | -97.06 |
| NCAV / Share | -4.32 |
| Price / NCAV | -0.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.86 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.14 |
| Current Ratio | 0.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 14.50 |
| Assets | 128.84 |
| Liabilities | 111.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| SCHEDULE 13D/A | Dragasac Ltd | |||
| 13G/A | UNITED THERAPEUTICS Corp | 4.11 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,729 | 59,137 | 11.38 | |
| 12,249 | 108,009 | 11.34 | |
| 14,790 | 51,614 | 28.66 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CDMO – Avid Bioservices, Inc. | CDTX – Cidara Therapeutics, Inc. |
| CDXC – ChromaDex Corporation | CELZ – Creative Medical Technology Holdings, Inc. |
| CGEN – Compugen Ltd. |
Financial data and stock pages provided by
Fintel.io